None
Quote | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
Last: | $ |
---|---|
Change Percent: | -4.60% |
Open: | $17.33 |
Close: | $16.40 |
High: | $17.38 |
Low: | $16.37 |
Volume: | 79,847 |
Last Trade Date Time: | 02/12/2020 04:43:03 pm |
News | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointme...
2024-03-18 16:15:01 ET Leerink Partners analyst issues BUY recommendation for MIRM on March 18, 2024 03:00PM ET. The previous analyst recommendation was Buy. MIRM was trading at $26.08 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
Message Board Posts | Mirum Pharmaceuticals Inc. (NYSE:MIRM)
Subject | By | Source | When |
---|---|---|---|
I agree ! | Ganz | investorshub | 01/30/2023 4:46:13 PM |
I'm not sure there's a more intriguing small | historyperson | investorshub | 01/30/2023 1:45:09 AM |
Float, smote, keep an eye on this one. | Ganz | investorshub | 01/25/2023 4:55:43 PM |
The float is so small | Cosa | investorshub | 01/23/2023 7:05:41 PM |
Riztheinvestor: CYDY buyout 50 bucks 2023 | Riztheinvestor | investorshangout | 04/06/2022 7:39:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Mirum Pharmaceuticals Inc. Company Name:
MIRM Stock Symbol:
NYSE Market:
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confide...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical compa...
SAN MATEO, Calif., March 25, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to target dysfunctional metabolic and fibrotic pathways, today announced the appointme...